Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.27% |
| 2 | Technology | 12.59% |
| 3 | Healthcare | 10.49% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRMN
1651
Garmin
GRMN
$60B
| $5.19M | 0.01% |
96,182
+64,757
| +206% | +$3.35M |
|
|
DISCK
1652
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $5.17M | 0.01% |
255,417
+116,478
| +84% | +$2.62M |
|
|
MNK
1653
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $5.16M | 0.01% |
138,157
-642,433
| -82% | -$25.5M |
|
|
ACBI
1654
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $5.16M | 0.01% |
284,394
+264,107
| +1,302% | +$4.81M |
|
|
ICPT
1655
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.16M | 0.01% |
88,819
-100,764
| -53% | -$10.9M |
|
1656
Pitney Bowes
PBI
$2.39B
| $5.12M | 0.01% |
365,075
-144,447
| -28% | -$1.98M |
|
|
P
1657
DELISTED
Pandora Media Inc
P
| $5.11M | 0.01% |
662,971
-2,049,532
| -76% | -$17.6M |
|
|
CAJ
1658
DELISTED
Canon, Inc.
CAJ
| $5.1M | 0.01% |
+148,666
| New | +$5.12M |
|
1659
New Mountain Finance
NMFC
$732M
| $5.1M | 0.01% |
357,731
+76,940
| +27% | +$1.09M |
|
|
MRNS
1660
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $5.09M | 0.01% |
+216,982
| New | +$2.43M |
|
|
ALOG
1661
DELISTED
Analogic Corp
ALOG
| $5.09M | 0.01% |
60,785
-25,442
| -30% | -$1.85M |
|
1662
Jabil
JBL
$35.8B
| $5.09M | 0.01% |
178,230
-300,670
| -63% | -$9.09M |
|
1663
Syndax Pharmaceuticals
SNDX
$1.82B
| $5.08M | 0.01% |
434,244
-326,959
| -43% | -$4.01M |
|
|
WCC
1664
WESCO International
WCC
$17.7B
| $5.07M | 0.01% |
87,023
-249,644
| -74% | -$13.4M |
|
1665
ABM Industries
ABM
$2.84B
| $5.07M | 0.01% |
121,435
-224,742
| -65% | -$9.57M |
|
1666
Pacific Biosciences
PACB
$370M
| $5.05M | 0.01% |
962,221
+485,375
| +102% | +$2.09M |
|
|
CBB
1667
DELISTED
Cincinnati Bell Inc.
CBB
| $5.05M | 0.01% |
+254,266
| New | +$5.01M |
|
1668
Sabesp
SBS
$18.7B
| $5.05M | 0.01% |
2,487,341
-1,230,367
| -33% | -$2.49M |
|
1669
PUT
Vale
VALE
$62.6B
| $5.04M | 0.01% |
+500,000
| New | +$5.03M |
|
|
GNBC
1670
DELISTED
Green Bancorp, Inc
GNBC
| $5.03M | 0.01% |
212,716
+116,975
| +122% | +$2.49M |
|
1671
Wingstop
WING
$3.18B
| $5.03M | 0.01% |
151,127
-79,214
| -34% | -$2.57M |
|
1672
Atlassian
TEAM
$37.8B
| $5.02M | 0.01% |
+142,787
| New | +$5.07M |
|
1673
Upland Software
UPLD
$15.4M
| $5.01M | 0.01% |
+23,668
| New | +$5.43M |
|
|
MDP
1674
DELISTED
Meredith Corporation
MDP
| $5M | 0.01% |
90,116
-212,560
| -70% | -$12M |
|
1675
Novavax
NVAX
$1.31B
| $5M | 0.01% |
219,210
+199,330
| +1,003% | +$4.46M |
|
Similar funds
Millennium Management's Q3 2017 Portfolio in Review
As of Q3 2017, Millennium Management held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Millennium Management deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Millennium Management's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Millennium Management added most to Salesforce in Q3 2017, an estimated $208M increase.
- Millennium Management's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Millennium Management fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Millennium Management's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Millennium Management opened 794 new positions and closed 737 in Q3 2017.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.